These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9327137)

  • 1. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    Bioconjug Chem; 1997; 8(5):724-9. PubMed ID: 9327137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    Bioconjug Chem; 1993; 4(1):78-84. PubMed ID: 8431515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.
    Vaidyanathan G; Zalutsky MR
    Nat Protoc; 2006; 1(2):707-13. PubMed ID: 17406300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent bearing acylation agent.
    Shankar S; Vaidyanathan G; Affleck DJ; Peixoto K; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2004 Oct; 31(7):909-19. PubMed ID: 15464393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
    Zalutsky MR; Narula AS
    Cancer Res; 1988 Mar; 48(6):1446-50. PubMed ID: 3345515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.
    Wilbur DS; Hadley SW; Hylarides MD; Abrams PG; Beaumier PA; Morgan AC; Reno JM; Fritzberg AR
    J Nucl Med; 1989 Feb; 30(2):216-26. PubMed ID: 2738650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
    Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
    Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
    Zalutsky MR; Noska MA; Colapinto EV; Garg PK; Bigner DD
    Cancer Res; 1989 Oct; 49(20):5543-9. PubMed ID: 2477144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepidermal growth factor variant III scFv fragment: effect of radioiodination method on tumor targeting and normal tissue clearance.
    Shankar S; Vaidyanathan G; Kuan CT; Bigner DD; Zalutsky MR
    Nucl Med Biol; 2006 Jan; 33(1):101-10. PubMed ID: 16459265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
    Reist CJ; Garg PK; Alston KL; Bigner DD; Zalutsky MR
    Cancer Res; 1996 Nov; 56(21):4970-7. PubMed ID: 8895752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of a convenient route to produce N-succinimidyl 4-radiodobenzoate for radioiodination of proteins.
    Araujo EB; Santos JS; Colturato MT; Muramoto E; Silva CP
    Appl Radiat Isot; 2003 Jun; 58(6):667-73. PubMed ID: 12798375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody.
    Foulon CF; Reist CJ; Bigner DD; Zalutsky MR
    Cancer Res; 2000 Aug; 60(16):4453-60. PubMed ID: 10969792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced binding and inertness to dehalogenation of alpha-melanotropic peptides labeled using N-succinimidyl 3-iodobenzoate.
    Garg PK; Alston KL; Welsh PC; Zalutsky MR
    Bioconjug Chem; 1996; 7(2):233-9. PubMed ID: 8983345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of MCF7 breast cancer cell line with 131I-PR81 monoclonal antibody against MUC1: comparison of direct and indirect radioiodination methods.
    Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Hasan ZM; Salouti M; Gandomkar M; Sadri K
    Hum Antibodies; 2010; 19(1):15-25. PubMed ID: 20555127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-succinimidyl 3-[(131)I]iodo-4-phosphonomethylbenzoate ([(131)I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs.
    Shankar S; Vaidyanathan G; Affleck D; Welsh PC; Zalutsky MR
    Bioconjug Chem; 2003; 14(2):331-41. PubMed ID: 12643743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal quality (131)I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN.
    Visser GW; Klok RP; Gebbinck JW; ter Linden T; van Dongen GA; Molthoff CF
    J Nucl Med; 2001 Mar; 42(3):509-19. PubMed ID: 11337531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of iodovinyl antibody conjugates: comparison with a p-iodobenzoyl conjugate and direct radioiodination.
    Hadley SW; Wilbur DS
    Bioconjug Chem; 1990; 1(2):154-61. PubMed ID: 2095212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability.
    Garg PK; Slade SK; Harrison CL; Zalutsky MR
    Int J Rad Appl Instrum B; 1989; 16(7):669-73. PubMed ID: 2613522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
    Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
    J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.